Ibutilide Fumarate

富马酸伊布利特

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIbutilide Fumarate
Drug Alias Name伊布利特ibutilidaibutilideibutilidumCorvert Injection +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersVoltage-gated potassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel
Therapy Area/IndicationsAtrial FlutterAtrial FibrillationArrhythmias, Cardiac
Global Approved IndicationsAtrial FlutterAtrial FibrillationArrhythmias, Cardiac
Approved Indications in ChinaArrhythmias, Cardiac
Original Approved Country/TerritoryUnited States
Original Approved Date1995/12/28
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmacia & UpjohnMaanshan Fengyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAtrial FlutterAtrial FibrillationArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeC01BD05
Related LinksWikipediaDrugBankKEGG